DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Han HS. Dieras V. Robson ME. et al.
Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study.
San Antonio Breast Cancer Symposium; Dec 2016
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.